X4 Pharmaceuticals (XFOR) Operating Margin Growth (1y) (2025)

X4 Pharmaceuticals (XFOR) Operating Margin Growth (1y) (2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (1y) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 1,552.00
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 1,536.00
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -170.00
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 1,049.00
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 X4 Pharmaceuticals 167.90 Mn -49.15 Mn 2.20 Mn 156,773.00

Historic Data

Download Data
DateValue
Dec 31, 2025 156,773.00
Sep 30, 2025 460,213.00
Jun 30, 2025 -1.40 Mn